MarketFriction

Fortis Healthcare Ltd

NSE FORTIS · BSE 532843 · Hospital
₹785.00 +1.95%
NSE close2026-10-01
52 week range757.45 - 1,104.30
Market cap₹62,058 Cr.
P/E58.2
Nifty 200Nifty 500Nifty Midcap 50Nifty Midcap 100Midcap 150Nifty Healthcare IndexNifty InfrastructureNifty India Consumption No price band Delivery 53.2%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,7701,6801,7861,8591,9881,9282,0072,1672,3312,2652,3652,545
Expenses1,4401,3961,4051,5161,5541,5531,5721,6761,7751,7591,8322,008
Operating Profit330284381343435375435491556506532537
OPM %19%17%21%18%22%19%22%23%24%22%23%21%
Other Income18191714-4247-293150-34-228
Interest323335353645687075868480
Depreciation848792919597102101106120122122
Profit before tax233183271230261279237351425266324363
Tax %21%27%25%24%26%9%21%24%23%26%16%25%
Net Profit184134203174193254188267329197271273
EPS in Rs2.301.782.372.202.343.282.443.454.262.573.523.53
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4,1994,5744,5614,4694,6324,0305,7186,2986,8937,7839,1289,506
Expenses4,1064,2204,2874,2384,0223,6264,6495,1965,6256,1957,0437,375
Operating Profit923542742316104041,0691,1011,2681,5882,0852,131
OPM %2.2%8%6%5%13%10%19%17%18%20%23%22%
Other Income299649-6892281269536715764-114542
Interest133229258337205166147129131184314325
Depreciation225222239233292291301316342386449470
Profit before tax34552-912-110239439888148581,0071,3661,378
Tax %-24%13%2%103%62%230%20%22%25%20%22%
Net Profit42479-934-22491-567906336458091,0641,070
EPS in Rs0.408.14-19.46-3.960.77-1.457.357.807.9310.2613.8013.88
Dividend Payout %0%0%0%0%0%0%0%13%13%10%7%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth8%18%13%18%
Compounded Profit Growth60%64%27%16%
Stock Price CAGR17%25%34%-15%
Return on Equity5%9%10%11%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital463463518519755755755755755755755755
Reserves3,5853,9984,6263,5435,8465,9065,3655,4236,4876,9088,1629,141
Borrowings1,7841,5132,2171,9622,0101,5941,5311,2559261,1552,4753,473
Other Liabilities1,7601,2572,2272,4552,8752,7813,2164,0823,9214,1531,9852,465
Total Liabilities7,5927,2329,5888,47911,48611,03610,86611,51612,08912,97113,37715,833
Fixed Assets4,2183,6425,4194,9928,4778,8028,7999,4169,4269,87410,42412,230
CWIP228226268226450204165193228542407434
Investments1,4641,4521,8781,732270175186104210230169243
Other Assets1,6821,9132,0231,5292,2901,8561,7161,8032,2252,3262,3782,926
Total Assets7,5927,2329,5888,47911,48611,03610,86611,51612,08912,97113,37715,833
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity24195966493-1791724858658221,1001,4241,601
Cash from Investing Activity213122-1,001-333-3,27963-131-501-372-889-780-1,537
Cash from Financing Activity-304-354259-6724,257-862-143-517-471-86-714164
Net Cash Flow-66-37225-513799-627212-153-21125-70228
Free Cash Flow-181-162689437-26135274750367172591673
CFO/OP131%354%304%187%30%84%108%101%100%104%97%90%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days383938384436413334333742
Inventory Days252323242230293331242324
Days Payable207218215279296226205178179164161165
Cash Conversion Cycle-144-156-155-217-230-161-135-112-115-107-101-99
Working Capital Days-71-69-87-113-234-150-56-35-22-124-30-34
ROCE %-0%3%11%3%6%4%2%10%10%10%12%13%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%31.17%
FIIs26.31%23.72%23.24%23.31%25.26%26.77%27.40%27.18%27.90%27.84%25.98%25.20%
DIIs26.55%29.42%31.14%32.31%30.73%30.05%29.46%29.79%29.14%29.33%31.35%32.23%
Public15.97%15.71%14.44%13.22%12.83%12.02%11.98%11.87%11.79%11.65%11.50%11.40%
No. of Shareholders1,31,5161,35,6641,57,1651,54,2602,04,1842,21,7502,18,3292,05,3732,20,7662,33,1562,26,6852,20,743

Fundamentals

Market Cap₹ 62,058 Cr.
Current Price₹ 822
Stock P/E58.2
Book Value₹ 131
ROCE13.4 %
ROE11.2 %
Dividend Yield0.12 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)18%
Compounded Profit Growth (TTM)16%
Consolidated figures.
Valuation
Market capRs 59,264 Cr
Enterprise valueRs 62,193 Cr
P/E (TTM)56.56x
Price to book5.99x
Price to sales6.23x
EV / EBITDA28.61x
EV / EBIT36.50x
EV / sales6.54x
Price to cash flow37.01x
Earnings yield1.77%
Dividend yield0.13%
P/E, 3-year average59.56x
P/B, 3-year average5.37x
P/E, 5-year average50.30x
P/B, 5-year average4.48x
Profitability
Operating margin (excl. other income)22.84%
Operating margin (incl. other income)23.33%
EBITDA margin22.87%
Pre-tax margin14.50%
Net profit margin11.02%
Net margin, latest quarter10.47%
ROE11.08%
ROCE13.57%
ROA7.13%
ROE, 3-year average9.48%
ROCE, 3-year average12.34%
ROA, 3-year average5.93%
ROE, 5-year average9.25%
ROCE, 5-year average12.83%
ROA, 5-year average5.55%
ROIC (approx.)10.35%
Tax rate22.09%
Other income / net worth0.45%
Growth
Sales growth (latest year)17.28%
Profit growth (latest year)34.56%
Sales CAGR, 3 years13.17%
Sales CAGR, 5 years17.76%
Profit CAGR, 3 years20.95%
Sales growth QoQ7.63%
Profit growth QoQ0.20%
Sales growth YoY (latest quarter)17.46%
Profit growth YoY (latest quarter)2.35%
Per share
EPS (TTM)Rs 13.88
EPS (latest year)Rs 13.80
EPS (latest quarter)Rs 3.53
EPS, 3-year averageRs 10.66
EPS, 5-year averageRs 9.43
Book value per shareRs 131.07
Sales per shareRs 125.92
Cash flow per shareRs 21.21
Free cash flow per shareRs 8.91
Dividend per share (latest year)Rs 1.00
Dividend per share, 3-year averageRs 1.00
Dividend per share, 5-year averageRs 1.00
Dividends
Dividend payout7.25%
Dividend payout, 3-year average9.87%
Dividend payout, 5-year average10.61%
Efficiency
Asset turnover0.58x
Fixed asset turnover0.75x
Inventory turnover35.33x
Inventory days10 days
Debtor days42 days
Debtors turnover8.75x
Creditor days165 days
Cash conversion cycle-99 days
Working capital days-34 days
Leverage
Total debtRs 3,473 Cr
Cash and bankRs 544 Cr
Net debtRs 2,929 Cr
Debt to equity0.35x
Net debt / EBITDA1.35x
Interest coverage5.24x
Current ratio (filing 2026-03-31)0.86x
Quick ratio (filing 2026-03-31)0.79x
Trade payables (filing 2026-03-31)Rs 943 Cr
Owners' fund to total sources62.50%
Debt to assets21.93%
Cash flow
Cash from Operating Activity (latest year)Rs 1,601 Cr
Cash from Investing Activity (latest year)Rs -1,537 Cr
Cash from Financing Activity (latest year)Rs 164 Cr
Net Cash Flow (latest year)Rs 228 Cr
Free cash flow (latest year)Rs 673 Cr
FCFE (approx.: FCF + change in debt)Rs 1,670 Cr
Cash from ops / profit, 5 years1.47x
Sales to cash flow5.70x
Statement figures
Net sales (TTM)Rs 9,506 Cr
Net sales (latest year)Rs 9,128 Cr
Sales (latest quarter)Rs 2,545 Cr
Operating profit excl. other income (latest year)Rs 2,085 Cr
Operating profit (latest quarter)Rs 537 Cr
Other income (TTM)Rs 42 Cr
EBITDA (TTM)Rs 2,174 Cr
PBDT (TTM)Rs 1,848 Cr
Profit before tax (TTM)Rs 1,378 Cr
Tax (latest year)Rs 302 Cr
Net profit (TTM)Rs 1,048 Cr
Net profit (latest year)Rs 1,042 Cr
Net profit (latest quarter)Rs 266 Cr
Depreciation (TTM)Rs 470 Cr
Depreciation (latest quarter)Rs 122 Cr
Interest (TTM)Rs 325 Cr
Cost of goods sold (latest year)Rs 4,779 Cr
Total expenditure (latest year)Rs 7,043 Cr
Total income (latest year)Rs 9,173 Cr
Share capitalRs 755 Cr
ReservesRs 9,141 Cr
Shareholders' fundsRs 9,896 Cr
Total assetsRs 15,833 Cr
Net blockRs 12,230 Cr
Capital work in progressRs 434 Cr
InvestmentsRs 243 Cr
ReceivablesRs 1,044 Cr
InventoryRs 135 Cr
Other liabilitiesRs 2,465 Cr
Shares outstanding (crore)75.50
Ownership
Promoter holding31.17% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 56.6 is at the 47th percentile of its own 6.4-year range (median 60.1, low 22.1, high 296.6).
P/B 5.99 is at the 78th percentile (median 3.23).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodFORTISNifty 50Difference
1 week-10.5%-2.8% -7.7 pts
1 month-14.2%-6.8% -7.4 pts
3 months-19.5%-7.6% -11.8 pts
6 months-1.3%+0.4% -1.7 pts
1 year-16.9%-9.9% -7.0 pts
2 years+31.2%-13.6% +44.7 pts
3 years+130.9%+14.2% +116.7 pts
5 years+195.4%+27.9% +167.6 pts
261 mutual fund schemes hold about ₹18,989 Cr. Over three months 206 bought more and 39 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
HDFC Mid Cap Fund2.69%2,911 +9%
Kotak Mid Cap Fund3.58%2,548 +12%
Nippon India Growth Mid Cap Fund2.61%1,364 +22%
Axis Midcap Fund3.21%1,103 +12%
DSP Midcap Fund2.79%587 +21%
HDFC Small Cap Fund1.08%453 -40%
HDFC Large & Mid Cap Fund1.42%429 +14%
Kotak Large & Mid Cap Fund1.32%426 +14%
Edelweiss Mid Cap Fund1.91%379 +5%
Kotak Arbitrage Fund(M0.46%347 +38%
DSP Large & Mid Cap Fund1.78%327 +63%
Axis ELSS-Tax Saver Fund0.94%306 +19%
Kotak Aggressive Hybrid Fund3.11%286 +13%
Axis Large & Mid Cap Fund1.60%278 +47%
Aditya Birla SL ELSS Tax Saver Fund1.86%271 +17%
Axis Large & Mid Cap Fund1.60%269 +47%
Sundaram Mid Cap Fund1.65%245 +11%
Sundaram Mid Cap Fund1.65%239 +11%
DSP ELSS Tax Saver Fund1.20%200 +17%
SBI Healthcare Opp Fund2.82%163 +22%
Axis Multicap Fund1.45%159 -0%
SBI ELSS Tax Saver Fund0.50%158 +100%
Kotak Focused Fund3.42%156 +11%
SBI Midcap Fund0.62%152 +100%
SBI Midcap Fund0.62%151 +100%

Red flags

F-score 6 of 8
lookRegulator order or action Regulator order or action 2026-01-02: Fortis Healthcare Limited has informed regarding GST Order received by Fortis Health Management Limited (Wholly owned subsidiary of Fortis
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2021-02-22ASHISH BHATIAEmployees/Designated Employesell34,415Rs 0.55 CrMarket Sale
2021-02-19ASHISH BHATIAEmployees/Designated Employesell5,241Rs 0.08 CrMarket Sale
2021-02-18ASHISH BHATIAEmployees/Designated Employesell310,354Rs 5.02 CrMarket Sale
2019-01-23Harinder Singh ChehalEmployees/Designated Employeother100,000Rs 0.91 CrESOP
2018-12-11ASHISH BHATIAEmployees/Designated Employeother300,000Rs 2.93 CrESOP
2018-12-06Anurag KalraEmployees/Designated Employeother55,000Rs 0.50 CrESOP
2018-07-23RHC HOLDING PVT LIIMITEDPromotersother218,250Rs 2.90 CrOthers
2018-07-23SHIVINDER MOHAN SINGHPromotersother11,508Rs 0.15 CrOthers
2018-07-23MALVINDER MOHAN SINGHPromotersother11,508Rs 0.15 CrOthers
2018-07-23MALAV HOLDINGS PVT LIMITEDPromotersother240,750Rs 3.20 CrOthers
2018-05-22FORTIS HEALTHCARE HOLDINGS PRIVATEPromotersother80,000Rs 1.19 CrInvocation of pledge
2018-05-02FORTIS HEALTHCARE HOLDINGS PRIVATEPromotersother57,600Rs 0.91 CrInvocation of pledge
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹2,545 Cr +17.4% vs Jun 2025. Net profit ₹273 Cr +2.2%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Apollo Hospitals Enterprise Ltd124,50359.217.4 %
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Aster DM Quality Care Ltd63,97617711.6 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Krishna Institute of Medical Sciences Ltd32,3361559.50 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Rainbow Childrens Medicare Ltd13,89248.517.4 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Healthcare Global Enterprises Ltd10,5052188.30 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
Artemis Medicare Services Ltd5,81850.414.5 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-07-24Dividend - Re 1 Per Share
2025-07-25Dividend - Re 1 Per Share
2024-07-24Dividend - Re 1 Per Share
2023-07-20Dividend - Re 1 Per Share
2016-09-16 Annual General Meeting
2015-09-14 Annual General Meeting
2014-09-18Annual General Meeting
2013-09-19Annual General Meeting
2012-09-21Annual General Meeting
2011-09-12Annual General Meeting
2010-09-13Annual General Meeting
2009-09-22Annual General Meeting
2009-08-18Rhts Eq 2:5 & 2 Wrnt:2 Eq
2008-09-10Annual General Meeting
2007-09-19Agm
DateTypeWhat it says
2026-09-29General UpdatesGeneral Updates on Announcement / Press release filed by IHH Healthcare Berhad ( IHH )
2026-09-27General UpdatesUpdate on Special Leave Petition (SLP) filed by the Company before The Honble Supreme Court of India
2026-09-25General UpdatesGeneral Updates on material Litigation filed by Northern TK Venture Pte Ltd. (NTK), the Promoter Shareholder of the Company, against Daiichi Sankyo Co...
2026-09-16Arrangements for strategic, Signing of Definitive Agreements by Fortis Hospotel Limited (wholly owned subsidiary of the Company) to provide Healthcare Services to a 400+ bedded S...
2026-09-16Press ReleaseA press release dated September 16, 2026, titled "Fortis Signs Definitive Agreements to provide Healthcare Services to a 400+ bedded Super Specialty H...
2026-09-16General UpdatesSigning the Definitive Agreements by Fortis Hospotel Limited (wholly owned subsidiary of the Company) to provide Healthcare Services to a 400+ bedded ...
2026-09-16General UpdatesFiling of Special Leave Petition ( SLP ) before the Hon ble Supreme Court of India
2026-09-15Concall / analyst meetSchedule of meet
2026-09-15Concall / analyst meetSchedule of meet
2026-09-11General UpdatesGeneral Updates
2026-09-10Concall / analyst meetTranscript of Investors / Analysts meet held on Friday, September 4, 2026, on the recent developments
2026-09-09Concall / analyst meetRevised Intimation for Schedule of Investors meet
2026-09-09Concall / analyst meetRevised intimation for Schedule of Investor meet
2026-09-09Concall / analyst meetSchedule of meet
2026-09-09Concall / analyst meetSchedule of meets.
2026-09-04Concall / analyst meetLink of Recording
2026-09-01Concall / analyst meetSchedule of meet
2026-09-01General UpdatesOrder Passed By The Hon Ble Delhi High Court In Relation To Certain Applications Filed By Daiichi Sankyo Company, Limited Inter Alia The Company. Deta...
2026-08-24General UpdatesGeneral Updates
2026-08-11Concall / analyst meetTranscript
2026-08-11Shareholder meetingShareholders meeting
2026-08-11Shareholder meetingProceedings of Annual General Meeting held on August 11, 2026
2026-08-07Concall / analyst meetLink of Recording
2026-08-06Investor PresentationInvestor Presentation
2026-08-06Press ReleaseA press release dated August 06, 2026, titled "Fortis Healthcare announces Q1 FY27 Financial Results".
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
Put / call open interest0.87
Max pain (expiry 2026-10-27)800
Largest call open interest at900
Largest put open interest at780
Implied volatility, at the money28.1%
Underlying at snapshot785.00
Open interest by strike around the price, nearest expiry. End-of-day NSE snapshot, 01-Oct-2026 15:40:00. Max pain is the strike where option buyers together would lose the most at expiry.
Trade dateShares sold short
2026-09-2820
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Order dateForumCase
2018-10-04NCLATSpectrum Voyages Pvt. Ltd. VS Fortis Healthcare Ltd.
2018-09-11NCLATSpectrum Voyages Pvt. Ltd. VS Fortis Healthcare Ltd.
2018-08-20NCLATSpectrum Voyages Pvt. Ltd. VS Fortis Healthcare Ltd.
2018-08-02NCLATSpectrum Voyages Pvt. Ltd. VS Fortis Healthcare Ltd.
Orders from NCLT, NCLAT and CESTAT naming the company. Click a row for the order.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Fortis Healthcare Ltd?

Fortis Healthcare Ltd (FORTIS) has a market capitalisation of Rs 62,058 Cr. at the 2026-10-01 close.

What is the P/E ratio of Fortis Healthcare Ltd?

Fortis Healthcare Ltd trades at a P/E of 58.2 on trailing twelve-month profit, at the 2026-10-01 close.

What were Fortis Healthcare Ltd's latest quarterly results?

In the Jun 2026 quarter, Fortis Healthcare Ltd sales was Rs 2,545 Cr (+17.4% vs Jun 2025) and net profit was Rs 273 Cr.

What is the 52-week high and low of Fortis Healthcare Ltd?

The 52-week high is Rs 1,104.30 and the 52-week low is Rs 757.45.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03